NO20080034L - Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer - Google Patents
Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorerInfo
- Publication number
- NO20080034L NO20080034L NO20080034A NO20080034A NO20080034L NO 20080034 L NO20080034 L NO 20080034L NO 20080034 A NO20080034 A NO 20080034A NO 20080034 A NO20080034 A NO 20080034A NO 20080034 L NO20080034 L NO 20080034L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- benzothiazol
- lipase
- phospholipase inhibitors
- phospholipase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005026809A DE102005026809A1 (de) | 2005-06-09 | 2005-06-09 | Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
PCT/EP2006/005096 WO2006131232A1 (de) | 2005-06-09 | 2006-05-27 | Benzothiazol-2-on-derivate als inhibitoren von lipasen und phospholipasen |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080034L true NO20080034L (no) | 2008-03-10 |
Family
ID=36699315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080034A NO20080034L (no) | 2005-06-09 | 2008-01-03 | Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer |
Country Status (21)
Country | Link |
---|---|
US (1) | US8008331B2 (es) |
EP (1) | EP1896435B1 (es) |
JP (1) | JP2008542411A (es) |
KR (1) | KR20080014020A (es) |
CN (1) | CN101189218A (es) |
AR (1) | AR054198A1 (es) |
AT (1) | ATE495163T1 (es) |
AU (1) | AU2006257023A1 (es) |
BR (1) | BRPI0611918A2 (es) |
CA (1) | CA2609560A1 (es) |
DE (2) | DE102005026809A1 (es) |
IL (1) | IL187729A0 (es) |
MA (1) | MA29482B1 (es) |
MX (1) | MX2007015269A (es) |
MY (1) | MY146803A (es) |
NO (1) | NO20080034L (es) |
NZ (1) | NZ564061A (es) |
RU (1) | RU2007145476A (es) |
TW (1) | TW200716581A (es) |
UY (1) | UY29594A1 (es) |
WO (1) | WO2006131232A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005026808A1 (de) * | 2005-06-09 | 2006-12-14 | Sanofi-Aventis Deutschland Gmbh | Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010044441A1 (ja) | 2008-10-17 | 2010-04-22 | 塩野義製薬株式会社 | 血管内皮リパーゼ阻害活性を有する酢酸アミド誘導体 |
CA2784710A1 (en) | 2009-12-15 | 2011-06-23 | Shionogi & Co., Ltd. | Oxadiazole derivative having endothelial lipase inhibitory activity |
CN101845027B (zh) * | 2010-05-28 | 2012-11-21 | 浙江工业大学 | 一种n-取代苯基-苯并噻唑酮-3-甲酰胺衍生物 |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2101150A1 (de) * | 1971-01-12 | 1972-08-03 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Substituierte Benzthiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Akarizide und Insektizide |
JPS60105671A (ja) * | 1983-11-14 | 1985-06-11 | Idemitsu Kosan Co Ltd | ベンゾチアゾロン誘導体、その製造方法およびそれを有効成分とする農園芸用殺菌剤 |
JPS61155376A (ja) * | 1984-12-28 | 1986-07-15 | Idemitsu Kosan Co Ltd | ベンゾチアゾロン誘導体,その製造方法およびそれを有効成分とする農園芸用殺菌剤 |
DE3835576A1 (de) * | 1988-03-25 | 1989-10-12 | Bayer Ag | 3,7-disubstituierte benzthiazolone |
BR0214967A (pt) * | 2001-12-14 | 2005-05-10 | Novo Nordisk As | Composto, sal famaceuticamente aceitável, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratar um distúrbio de um paciente |
DE10247680B4 (de) * | 2002-10-12 | 2005-09-01 | Aventis Pharma Deutschland Gmbh | Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase |
-
2005
- 2005-06-09 DE DE102005026809A patent/DE102005026809A1/de not_active Withdrawn
-
2006
- 2006-05-27 BR BRPI0611918-2A patent/BRPI0611918A2/pt not_active IP Right Cessation
- 2006-05-27 KR KR1020077028744A patent/KR20080014020A/ko not_active Application Discontinuation
- 2006-05-27 DE DE502006008717T patent/DE502006008717D1/de active Active
- 2006-05-27 WO PCT/EP2006/005096 patent/WO2006131232A1/de not_active Application Discontinuation
- 2006-05-27 JP JP2008515096A patent/JP2008542411A/ja not_active Abandoned
- 2006-05-27 MX MX2007015269A patent/MX2007015269A/es active IP Right Grant
- 2006-05-27 RU RU2007145476/04A patent/RU2007145476A/ru not_active Application Discontinuation
- 2006-05-27 CA CA002609560A patent/CA2609560A1/en not_active Abandoned
- 2006-05-27 CN CNA2006800199269A patent/CN101189218A/zh active Pending
- 2006-05-27 AU AU2006257023A patent/AU2006257023A1/en not_active Abandoned
- 2006-05-27 AT AT06753938T patent/ATE495163T1/de active
- 2006-05-27 EP EP06753938A patent/EP1896435B1/de active Active
- 2006-05-27 NZ NZ564061A patent/NZ564061A/en not_active IP Right Cessation
- 2006-06-07 TW TW095120138A patent/TW200716581A/zh unknown
- 2006-06-07 MY MYPI20062624A patent/MY146803A/en unknown
- 2006-06-07 AR ARP060102371A patent/AR054198A1/es not_active Application Discontinuation
- 2006-06-09 UY UY29594A patent/UY29594A1/es not_active Application Discontinuation
-
2007
- 2007-11-22 MA MA30416A patent/MA29482B1/fr unknown
- 2007-11-28 IL IL187729A patent/IL187729A0/en unknown
- 2007-12-05 US US11/950,948 patent/US8008331B2/en not_active Expired - Fee Related
-
2008
- 2008-01-03 NO NO20080034A patent/NO20080034L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL187729A0 (en) | 2008-08-07 |
MA29482B1 (fr) | 2008-05-02 |
JP2008542411A (ja) | 2008-11-27 |
ATE495163T1 (de) | 2011-01-15 |
DE502006008717D1 (de) | 2011-02-24 |
TW200716581A (en) | 2007-05-01 |
US8008331B2 (en) | 2011-08-30 |
CA2609560A1 (en) | 2006-12-14 |
EP1896435B1 (de) | 2011-01-12 |
AR054198A1 (es) | 2007-06-06 |
MX2007015269A (es) | 2008-02-21 |
UY29594A1 (es) | 2007-01-31 |
NZ564061A (en) | 2010-07-30 |
EP1896435A1 (de) | 2008-03-12 |
MY146803A (en) | 2012-09-28 |
US20080161370A1 (en) | 2008-07-03 |
BRPI0611918A2 (pt) | 2010-10-05 |
WO2006131232A1 (de) | 2006-12-14 |
CN101189218A (zh) | 2008-05-28 |
DE102005026809A1 (de) | 2006-12-14 |
KR20080014020A (ko) | 2008-02-13 |
AU2006257023A1 (en) | 2006-12-14 |
RU2007145476A (ru) | 2009-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081878L (no) | Diacylindazolderivater som lipase- og fosfolipaseinhibitorer | |
NO20082159L (no) | Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser | |
NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
NO20063925L (no) | Indazolderivater som inhibitorer av hormonsensitiv lipase | |
TW200722421A (en) | Azole derivatives as inhibitors of lipases and phospholipases | |
TW200730513A (en) | Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases | |
NO20080035L (no) | Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
DK2324008T3 (da) | Diarylpyrazol som protein kinase inhibitorer | |
NO20080133L (no) | Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer | |
UA99284C2 (ru) | ИНГИБИТОРЫ р70 S6-КИНАЗЫ | |
MX2009010485A (es) | Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas. | |
NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
WO2008101682A3 (en) | Iminipyridine derivatives and their uses as microbiocides | |
TW200716628A (en) | Novel compounds | |
NO20055496L (no) | Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer | |
EA200900613A1 (ru) | Спирокетоновые ингибиторы ацетил-коа-карбоксилаз | |
CY1113314T1 (el) | (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης | |
NO20080034L (no) | Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors | |
MX2009010483A (es) | 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas. | |
NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
ATE487721T1 (de) | Triaza-benzoäeüazulenderivate zur behandlung von tumoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |